Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Goëb

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Rheumatology Advances in Practice|April 9, 2025
BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritisMartin Rudwaleit, Victoria Navarro-Compán, Hagen Russ, et al.
Journal of Clinical Medicine|January 8, 2023
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk WarningsCécile Philippoteaux, Valentine Deprez, Aurore Nottez, et al.
Journal of Clinical Medicine|October 21, 2020
Therapeutic Maintenance of Baricitinib and Tofacitinib in Real LifeValentine Deprez, Laure Le Monnier, Jean-Marc Sobhy-Danial, et al.
Joint Bone Spine|November 18, 2011
Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide seriesÉric Toussirot, Éric Houvenagel, Vincent Goëb, et al.
Annals of the Rheumatic Diseases|August 31, 2013
An immunological biomarker to predict MTX response in early RAFrederique Ponchel, Vincent Goëb, Rekha Parmar, et al.
Arthritis Research & Therapy|October 7, 2005
Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritisVincent Goëb, Philippe Dieudé, Olivier Vittecoq, et al.
Journal of Clinical Medicine|May 23, 2020
Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric NetworkJean-Hugues Salmon, Jean-Guillaume Letarouilly, Vincent Goëb, et al.
European Journal of Gastroenterology & Hepatology|April 22, 2016
Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximabHenri Thiebault, Pauline Boyard-Lasselin, Caroline Guignant, et al.
Rheumatology (Oxford, England)|April 28, 2009
Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective studyDamien Fouache, Vincent Goëb, Nathalie Massy-Guillemant, et al.
Rheumatology and Therapy|January 12, 2019
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch StudyJean Darloy, Nicolas Segaud, Jean-Hugues Salmon, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Rheumatology Advances in Practice|April 9, 2025
BASDAI and ASDAS disease states in relationship to ASAS40 response: post hoc analysis of ixekizumab in radiographic axial spondyloarthritisMartin Rudwaleit, Victoria Navarro-Compán, Hagen Russ, et al.
Journal of Clinical Medicine|January 8, 2023
Characteristics of Patients Treated with JAK Inhibitors in Rheumatoid Arthritis before versus after VTE Risk WarningsCécile Philippoteaux, Valentine Deprez, Aurore Nottez, et al.
Journal of Clinical Medicine|October 21, 2020
Therapeutic Maintenance of Baricitinib and Tofacitinib in Real LifeValentine Deprez, Laure Le Monnier, Jean-Marc Sobhy-Danial, et al.
Joint Bone Spine|November 18, 2011
Development of inflammatory bowel disease during anti-TNF-α therapy for inflammatory rheumatic disease: a nationwide seriesÉric Toussirot, Éric Houvenagel, Vincent Goëb, et al.
Annals of the Rheumatic Diseases|August 31, 2013
An immunological biomarker to predict MTX response in early RAFrederique Ponchel, Vincent Goëb, Rekha Parmar, et al.
Arthritis Research & Therapy|October 7, 2005
Association between the TNFRII 196R allele and diagnosis of rheumatoid arthritisVincent Goëb, Philippe Dieudé, Olivier Vittecoq, et al.
Journal of Clinical Medicine|May 23, 2020
Actual Persistence of Abatacept in Rheumatoid Arthritis: Results of the French-Ric NetworkJean-Hugues Salmon, Jean-Guillaume Letarouilly, Vincent Goëb, et al.
European Journal of Gastroenterology & Hepatology|April 22, 2016
Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximabHenri Thiebault, Pauline Boyard-Lasselin, Caroline Guignant, et al.
Rheumatology (Oxford, England)|April 28, 2009
Paradoxical adverse events of anti-tumour necrosis factor therapy for spondyloarthropathies: a retrospective studyDamien Fouache, Vincent Goëb, Nathalie Massy-Guillemant, et al.
Rheumatology and Therapy|January 12, 2019
Tocilizumab Effectiveness After Switching from Intravenous to Subcutaneous Route in Patients with Rheumatoid Arthritis: The RoSwitch StudyJean Darloy, Nicolas Segaud, Jean-Hugues Salmon, et al.
Pageof 7